Literature DB >> 5655316

Probenecid, nephrotic syndrome, and renal failure.

J T Scott, P K O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5655316      PMCID： PMC1031103          DOI： 10.1136/ard.27.3.249

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS.

Authors:  A P HALL; V P HOLLOWAY; J T SCOTT
Journal:  Ann Rheum Dis       Date:  1964-11       Impact factor: 19.103

2.  Nephrotic syndrome caused by probenecid.

Authors:  T F FERRIS; W S MORGAN; H LEVITIN
Journal:  N Engl J Med       Date:  1961-08-24       Impact factor: 91.245

3.  The kidney in gout.

Authors:  J H TALBOTT; K L TERPLAN
Journal:  Medicine (Baltimore)       Date:  1960-12       Impact factor: 1.889

4.  Renal changes in gout.

Authors:  J BROWN; G K MALLORY
Journal:  N Engl J Med       Date:  1950-08-31       Impact factor: 91.245

5.  Nephrotic syndrome caused by probenecid.

Authors:  A Sokol; M H Bashner; R Okun
Journal:  JAMA       Date:  1967-01-02       Impact factor: 56.272
  5 in total
  8 in total

1.  Drug-induced renal diseases.

Authors:  A P Mukherjee
Journal:  Int Urol Nephrol       Date:  1974       Impact factor: 2.370

2.  Probenecid and renal failure.

Authors: 
Journal:  Br Med J       Date:  1968-09-07

3.  Clinical survey of 354 patients with gout.

Authors:  R Grahame; J T Scott
Journal:  Ann Rheum Dis       Date:  1970-09       Impact factor: 19.103

Review 4.  Long-term management of gout and hyperuricaemia.

Authors:  J T Scott
Journal:  Br Med J       Date:  1980-11-01

5.  [Toxic nephropathies (author's transl)].

Authors:  E Heidbreder; A Heidland
Journal:  Klin Wochenschr       Date:  1980-02-01

6.  Comparative study of the effect of three antibiotics on renal function.

Authors:  A D Caldwell; A J Martin; D J Trigger
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

Review 7.  Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature review.

Authors:  Hamish Farquhar; Ana B Vargas-Santos; Huai Leng Pisaniello; Mark Fisher; Catherine Hill; Angelo L Gaffo; Lisa K Stamp
Journal:  Rheumatol Adv Pract       Date:  2021-01-04

Review 8.  Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy.

Authors:  Julie Gutman; S Patrick Kachur; Laurence Slutsker; Alexis Nzila; Theonest Mutabingwa
Journal:  Malar J       Date:  2012-02-09       Impact factor: 2.979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.